MDGL logo

Madrigal Pharmaceuticals, Inc. (MDGL) Free Cash Flow

Annual FCF:

-$462.03M-$136.32M(-41.85%)
December 31, 2024

Summary

  • As of today, MDGL annual free cash flow is -$462.03 million, with the most recent change of -$136.32 million (-41.85%) on December 31, 2024.
  • During the last 3 years, MDGL annual free cash flow has fallen by -$277.91 million (-150.93%).
  • MDGL annual free cash flow is now -1957.65% below its all-time high of $24.87 million, reached on December 31, 2007.

Performance

MDGL Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLcash flow metrics

Quarterly FCF:

-$47.05M+$41.84M(+47.07%)
June 30, 2025

Summary

  • As of today, MDGL quarterly free cash flow is -$47.05 million, with the most recent change of +$41.84 million (+47.07%) on June 30, 2025.
  • Over the past year, MDGL quarterly free cash flow has increased by +$93.02 million (+66.41%).
  • MDGL quarterly free cash flow is now -169.70% below its all-time high of $67.51 million, reached on December 31, 2007.

Performance

MDGL Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLcash flow metrics

TTM FCF:

-$308.39M+$93.02M(+23.17%)
June 30, 2025

Summary

  • As of today, MDGL TTM free cash flow is -$308.39 million, with the most recent change of +$93.02 million (+23.17%) on June 30, 2025.
  • Over the past year, MDGL TTM free cash flow has increased by +$147.43 million (+32.34%).
  • MDGL TTM free cash flow is now -1117.60% below its all-time high of $30.31 million, reached on June 30, 2016.

Performance

MDGL TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

MDGL Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-41.9%+66.4%+32.3%
3Y3 Years-150.9%+18.1%-53.3%
5Y5 Years-1005.5%-93.9%-167.3%

MDGL Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-150.9%at lowat high+68.5%-43.6%+33.3%
5Y5-Year-1005.5%at low-8.2%+68.5%-167.3%+33.3%
All-TimeAll-Time-1957.7%at low-169.7%+68.5%-1117.6%+33.3%

MDGL Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$47.05M(+47.1%)
-$308.39M(+23.2%)
Mar 2025
-
-$88.89M(+15.1%)
-$401.41M(+13.1%)
Dec 2024
-$462.03M(-41.9%)
-$104.68M(-54.5%)
-$462.03M(-5.4%)
Sep 2024
-
-$67.76M(+51.6%)
-$438.32M(+3.8%)
Jun 2024
-
-$140.08M(+6.3%)
-$455.82M(-16.5%)
Mar 2024
-
-$149.51M(-84.7%)
-$391.12M(-20.1%)
Dec 2023
-$325.71M(-44.7%)
-$80.97M(+5.0%)
-$325.71M(-7.4%)
Sep 2023
-
-$85.26M(-13.1%)
-$303.28M(-9.4%)
Jun 2023
-
-$75.38M(+10.4%)
-$277.13M(-6.9%)
Mar 2023
-
-$84.10M(-43.7%)
-$259.21M(-15.2%)
Dec 2022
-$225.07M(-22.2%)
-$58.54M(+0.9%)
-$225.07M(-4.8%)
Sep 2022
-
-$59.10M(-2.9%)
-$214.69M(-6.7%)
Jun 2022
-
-$57.46M(-15.0%)
-$201.20M(-5.6%)
Mar 2022
-
-$49.97M(-3.7%)
-$190.62M(-3.5%)
Dec 2021
-$184.13M(-16.6%)
-$48.16M(-5.6%)
-$184.13M(+3.6%)
Sep 2021
-
-$45.61M(+2.7%)
-$190.92M(+1.2%)
Jun 2021
-
-$46.88M(-7.8%)
-$193.17M(-13.3%)
Mar 2021
-
-$43.47M(+20.9%)
-$170.55M(-8.0%)
Dec 2020
-$157.90M(-277.8%)
-$54.96M(-14.8%)
-$157.90M(-36.9%)
Sep 2020
-
-$47.85M(-97.2%)
-$115.35M(-46.3%)
Jun 2020
-
-$24.27M(+21.3%)
-$78.82M(-19.3%)
Mar 2020
-
-$30.82M(-148.2%)
-$66.10M(-58.1%)
Dec 2019
-$41.80M(-63.7%)
-$12.42M(-9.7%)
-$41.80M(-17.2%)
Sep 2019
-
-$11.32M(+1.9%)
-$35.65M(-20.5%)
Jun 2019
-
-$11.54M(-77.0%)
-$29.58M(-26.4%)
Mar 2019
-
-$6.52M(-3.9%)
-$23.40M(+8.3%)
Dec 2018
-$25.53M(-13.8%)
-$6.27M(-19.5%)
-$25.53M(-1.3%)
Sep 2018
-
-$5.25M(+2.0%)
-$25.20M(-1.2%)
Jun 2018
-
-$5.36M(+38.0%)
-$24.90M(+8.8%)
Mar 2018
-
-$8.64M(-45.4%)
-$27.31M(-21.7%)
Dec 2017
-$22.44M(-27.4%)
-$5.95M(-20.1%)
-$22.44M(-3.0%)
Sep 2017
-
-$4.95M(+36.3%)
-$21.78M(+16.5%)
Jun 2017
-
-$7.77M(-106.0%)
-$26.07M(-24.5%)
Mar 2017
-
-$3.77M(+28.6%)
-$20.95M(-18.9%)
Dec 2016
-$17.61M(-460.5%)
-$5.28M(+42.9%)
-$17.61M(-31.2%)
Sep 2016
-
-$9.24M(-249.2%)
-$13.43M(-144.3%)
Jun 2016
-
-$2.65M(-504.3%)
$30.31M(+99.4%)
Mar 2016
-
-$438.00K(+60.0%)
$15.20M(+583.6%)
Dec 2015
-$3.14M
-$1.10M(-103.2%)
-$3.14M(+85.3%)
DateAnnualQuarterlyTTM
Sep 2015
-
$34.49M(+294.2%)
-$21.32M(+71.3%)
Jun 2015
-
-$17.76M(+5.4%)
-$74.41M(+4.1%)
Mar 2015
-
-$18.77M(+2.6%)
-$77.55M(+1.9%)
Dec 2014
-$79.07M(-1.1%)
-$19.27M(-3.6%)
-$79.07M(-32.2%)
Sep 2014
-
-$18.60M(+11.0%)
-$59.80M(-45.2%)
Jun 2014
-
-$20.90M(-3.0%)
-$41.19M(-1.4%)
Mar 2014
-
-$20.29M(+0.1%)
-$40.61M(+41.0%)
Dec 2013
-$78.18M(-43.1%)
-
-
Jun 2013
-
-$20.31M(+9.7%)
-$68.88M(-11.6%)
Mar 2013
-
-$22.49M(-78.4%)
-$61.73M(-13.0%)
Dec 2012
-$54.64M(-13.9%)
-$12.61M(+6.4%)
-$54.64M(-3.3%)
Sep 2012
-
-$13.47M(-2.4%)
-$52.90M(-2.7%)
Jun 2012
-
-$13.16M(+14.6%)
-$51.51M(-1.9%)
Mar 2012
-
-$15.40M(-41.7%)
-$50.54M(-5.3%)
Dec 2011
-$47.99M(-25.2%)
-$10.87M(+10.1%)
-$47.99M(-5.8%)
Sep 2011
-
-$12.08M(+0.9%)
-$45.36M(-8.6%)
Jun 2011
-
-$12.19M(+5.1%)
-$41.77M(-8.2%)
Mar 2011
-
-$12.85M(-56.0%)
-$38.59M(-0.7%)
Dec 2010
-$38.34M(-40.6%)
-$8.24M(+3.0%)
-$38.34M(-2.8%)
Sep 2010
-
-$8.49M(+5.7%)
-$37.30M(-0.6%)
Jun 2010
-
-$9.01M(+28.4%)
-$37.09M(+28.3%)
Mar 2010
-
-$12.59M(-74.7%)
-$51.70M(-89.6%)
Dec 2009
-$27.26M(+32.0%)
-$7.21M(+13.0%)
-$27.26M(-540.6%)
Sep 2009
-
-$8.28M(+64.9%)
-$4.26M(+73.8%)
Jun 2009
-
-$23.62M(-299.4%)
-$16.25M(-33.6%)
Mar 2009
-
$11.84M(-25.1%)
-$12.16M(+69.7%)
Dec 2008
-$40.12M(-261.3%)
$15.80M(+177.9%)
-$40.12M(-446.5%)
Sep 2008
-
-$20.27M(-3.8%)
$11.58M(-26.7%)
Jun 2008
-
-$19.54M(-21.2%)
$15.79M(-29.6%)
Mar 2008
-
-$16.11M(-123.9%)
$22.43M(-9.8%)
Dec 2007
$24.87M(+145.6%)
$67.51M(+520.2%)
$24.87M(+145.8%)
Sep 2007
-
-$16.07M(-24.6%)
-$54.34M(-42.0%)
Jun 2007
-
-$12.90M(+5.7%)
-$38.27M(-50.8%)
Mar 2007
-
-$13.67M(-16.8%)
-$25.37M(-116.8%)
Dec 2006
-$54.56M(+18.3%)
-$11.70M(+17.6%)
-$11.70M(+17.6%)
Dec 2005
-$66.77M(-88.7%)
-
-
Mar 2005
-
-$14.20M
-$14.20M
Dec 2004
-$35.39M(-45.1%)
-
-
Dec 2003
-$24.38M
-
-

FAQ

  • What is Madrigal Pharmaceuticals, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. annual free cash flow year-on-year change?
  • What is Madrigal Pharmaceuticals, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
  • What is Madrigal Pharmaceuticals, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

What is Madrigal Pharmaceuticals, Inc. annual free cash flow?

The current annual free cash flow of MDGL is -$462.03M

What is the all-time high annual free cash flow for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high annual free cash flow is $24.87M

What is Madrigal Pharmaceuticals, Inc. annual free cash flow year-on-year change?

Over the past year, MDGL annual free cash flow has changed by -$136.32M (-41.85%)

What is Madrigal Pharmaceuticals, Inc. quarterly free cash flow?

The current quarterly free cash flow of MDGL is -$47.05M

What is the all-time high quarterly free cash flow for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high quarterly free cash flow is $67.51M

What is Madrigal Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?

Over the past year, MDGL quarterly free cash flow has changed by +$93.02M (+66.41%)

What is Madrigal Pharmaceuticals, Inc. TTM free cash flow?

The current TTM free cash flow of MDGL is -$308.39M

What is the all-time high TTM free cash flow for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high TTM free cash flow is $30.31M

What is Madrigal Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

Over the past year, MDGL TTM free cash flow has changed by +$147.43M (+32.34%)
On this page